Anne‐Marie Ray

Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors

Florence Schaffner, Anne‐Marie Ray, Monique Dontenwill · Cancers · 2013 · 228 citations · Full text

Medicine, Cell Biology, Oncology +15

Sulfonamido-2-arylbenzoxazole GroEL/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)

Sanofar Abdeen, Trent Kunkle, Nilshad Salim et al. · Journal of Medicinal Chemistry · 2018 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells

Hana Janoušková, Anne‐Marie Ray, Fanny Noulet et al. · Cancer Letters · 2013 · 46 citations

Life Sciences, Cell Biology, Oncology +14

Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties

Alain C. Jung, Anne‐Marie Ray, Ludivine Ramolu et al. · Oncotarget · 2015 · 38 citations · Full text

Medicine, Oncology, Pathology +15

RNA Aptamers Targeting Integrin α5β1 as Probes for Cyto- and Histofluorescence in Glioblastoma

Pierre Fechter, Elisabete Cruz Da Silva, Marie-Cécile Mercier et al. · Molecular Therapy — Nucleic Acids · 2019 · 38 citations · Full text

Medicine, Molecular Biology, Oncology +15